Navigation Links
VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
Date:8/18/2011

SHANGHAI, Aug. 18, 2011 /PRNewswire-Asia/ -- VacChina 2011 -- China's largest vaccine meeting -- welcomes world class biotechs and pharmas to discuss the opportunities of development of novel vaccine R&D and manufacturing technologies in China.

The World Health Organization (WHO) announced on March 1, 2011, that the national regulatory authority of China -- the State Food and Drug Administration (SFDA), along with affiliated institutions -- now meets WHO indicators for a functional vaccine regulatory system. This means that Chinese-made vaccines are now eligible to apply for WHO pre-qualification. On the same day as this WHO announcement, the China SFDA also adopted a new Good Manufacturing Practice code. The new code puts in place stricter requirements for vaccine production, in line with international standards, in order to ensure quality.

The announcement will motivate domestic manufacturers to strengthen vaccine development partnerships with international organizations at broader and more strategic levels. More government funding will also pour into companies working toward the goal of WHO pre-qualification. Furthermore, a new interest in vaccine technology will encourage Chinese scientists who are now working overseas to return to the country in order to leverage this opportunity.

Supported by BayHelix and hosted by Global Leaders Institute, world vaccine industry leaders will convene at VacChina 2011 on Nov 29 and 30 in Shanghai. The two-day executive summit will explore the major partnering opportunities in the vaccine industry in China. The goal of the summit is to bridge the China vaccine industry with the world class biotechnologies in terms of vaccine R&D and production.

Key issues to be addressed:

  • The requirements or the process of WHO pre-qualification, UNICEF procurement programs, or GAVI's working mechanisms
  • How to align China SFDA's regulatory pathways and domestic clinical trials with international standards and requirements
  • What do new Chinese Good Manufacturing Practice (GMP) standards and WHO approval for China's vaccine regulatory system mean for China's vaccine industry? Now that Chinese vaccine manufacturers can apply for WHO prequalification, will China take on a bigger role as a global vaccine supplier? Should we expect China to take a larger role developing novel vaccines?
  • What kind of assistance do SFDA, CDC and Chinese manufacturers need from international partners (WHO, UNICEF, PATH, etc) to improve and meet international standards? How will China respond to international concerns about quality and safety of Chinese vaccines?
  • Novel approaches to cell culture to accelerate development and quality control
  • How to improve cost and time to the clinic and ensure product quality through downstream processing
  • Strategies to accelerate vaccine development process with the latest expression and characterization technologies

For more information, please visit vac.globaleaders.com or contact:

Daniel Chen
Tel: +86-21-3251-6046 or email: daniel.chen@globaleaders.com


'/>"/>
SOURCE Global Leaders Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vaccine Leaders All Over the World Talking About China Vaccine Opportunities at VacChina 2010 -- the No.1 China Focused Vaccine Partnering Forum
2. VacChina 2010 - A Premium Event to Define the Vaccine Industry in Asia
3. TRIA Beauty Leading the Charge in Bridging Gap Between Science and Skin Health
4. PAREXEL Achieves 100th Asian Ethnobridging Study Milestone
5. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
6. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
7. China Contract Research Organization (CRO) Industry Report, 2010-2011
8. Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market
9. China Nuvo Solar Target Acquisition SurgLine Updates OptiMedical Corp.s Sales Forecast in Excess of $10,000,000
10. China Medical Technologies Reports First Fiscal Quarter Financial Results
11. Chairman of Global Guide to COPD Diagnosis Committee Visited West China Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, 2016 ... today announced they will form a partnership to ... medicine in cancer. The goal of the collaboration ... with Macrogen,s high-throughput Next Generation Sequencing capabilities toward ... Laboratory Improvement Amendments (CLIA) of 1988 by the ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
(Date:2/11/2016)... -- Stem cells are primitive cells found in all ... capacity to differentiate into mature cell types Stem cells ... mouse embryonic stem cells were derived from embryos in ... first culturing of embryonic stem cells from non-human primates ... 2006 As a result of these discoveries, stem cells ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... , ... The producers of Enterprises TV are pleased to present ... world of instantaneous consumption proves very convenient for businesses. With new technologies constantly becoming ... which pollutes our air, water, and soil. It can also threaten the lives of ...
(Date:2/13/2016)... , ... February 13, 2016 , ... In the early ... They’ll groom themselves to perfection, go out of their way to be romantic, and ... just take a look at any online dating profile. , A recent study ...
(Date:2/12/2016)... ... 2016 , ... The law firm of Morrow, Morrow, Ryan & Bassett is ... these scholarships is to encourage applicants to pursue a degree in their field of ... parishes. , “We have available jobs in St. Landry and Evangeline Parishes that ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed ... p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed ... pharmaceutical products, garnering increased attention from all stakeholders in the development of new ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... that nominations have closed for the ISE Southeast Awards 2016. Finalists and winners ... at the ISE® Southeast Executive Forum and Awards Gala on March 15, 2016 ...
Breaking Medicine News(10 mins):